R. Riessen et al., Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells, BAS R CARD, 94(5), 1999, pp. 322-332
Clinical studies have shown that treatment with 3-hydroxy-3-methylglutaryl-
coenzyme A (HMG-CoA) reductase inhibitors can stabilize atherosclerotic pla
ques and slow their progression. One determinant of plaque stability and si
ze is the composition of the vascular extracellular matrix. The aim of this
study was to evaluate the effects of different HMG-CoA reductase inhibitor
s on the expression of major components of the vascular extracellular matri
x in smooth muscle cells.
Cultured human vascular smooth muscle cells were incubated for 24-72 h with
the HMG-CoA reductase inhibitors lovastatin (1-50 mu mol/L), simvastatin (
0.05-20 mu mol/L), and pravastatin (1-100 mu mol/L). RNA expression of the
extracellular matrix proteins thrombospondin-1, fibronectin, collagen type
I, and biglycan as well as expression of the cytokine TGF-beta 1 was determ
ined by Northern blotting. Extracellular matrix protein secretion was visua
lized by immunofluorescence. In addition, cell proliferation and viability
were measured using BrDUELISAs, MTT-tests, and direct cell counting.
Expression of thrombospondin-1 was significantly decreased after 24 h incub
ations with lovastatin in concentrations as low as 1 mu mol/L. Coincubation
with the cholesterol precursor mevalonate completely reversed this effect.
The downregulation of thrombospondin-1 expression occured in the same conc
entration range that also inhibited cell proliferation. In contrast, lovast
atin did not affect expression of fibronectin, whereas collagen type I and
biglycan expression decreased only after long incubations with high, toxic
lovastatin concentrations. Simvastatin, but not the very hydrophilic compou
nd pravastatin, had a similar effect on extracellular matrix expression as
lovastatin.
In summary, lovastatin and simvastatin predominantly decrease the expressio
n of the glycoprotein thrombospondin-1, which is functionally associated wi
th smooth muscle cell migration and proliferation. In contrast, expression
of plaque-stabilizing extracellular proteins such as collagen type I and bi
glycan are much less affected.